Chart speaks for itself. Marijuana rescheduling (from 1 to 3) is all but set in stone. DEA sources have confirmed as of today 3/15 which triggered a wave of upticks in US Cannabis stocks all traded on the OTC except the ETF MSOS and MSOX. DEA rescheduling would allow US Cannabis stocks to uplist to US exchanges as well as get 280E tax deductions
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.